Influenza A virus vaccine H7N9 - Adimmune Corporation

Drug Profile

Influenza A virus vaccine H7N9 - Adimmune Corporation

Alternative Names: AdimFlu-A

Latest Information Update: 14 Dec 2015

Price : $50

At a glance

  • Originator Adimmune Corporation
  • Class Influenza A vaccines; Influenza A virus H7N9 vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase III Influenza A virus H7N9 subtype

Most Recent Events

No Data Available
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top